Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 11:44 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 81 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Blinded - CGM Clear all

Conditions: Diabetes Mellitus, Type 2, Hypoglycemia
Interventions: FreeStyle Libre 2 CGM, FreeStyle Libre Pro blinded CGM, FreeStyle Precision Neo blood glucose meter; Device
Lead sponsor: Palo Alto Medical Foundation; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 2
States / cities: Palo Alto, California • Atlanta, Georgia

Conditions: Type 2 Diabetes
Interventions: Dexcom continuous glucose monitor; Device
Lead sponsor: Ian J. Neeland, MD; Other
Eligibility: 18 Years to 99 Years
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Type2 Diabetes
Interventions: Abbott Freestyle Libre Pro, LifeStyle; Device · Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 21 Years to 70 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Diabetes, Hypoglycemia
Interventions: 13C-MRS procedure/Acetate infusion, Continuous glucose monitoring; Other · Device
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 18 Years to 40 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 2
States / cities: Baton Rouge, Louisiana • New Orleans, Louisiana

Conditions: Type 2 Diabetes
Interventions: SMBG to guide clinical decisions, SMBG and CGM; Other
Lead sponsor: HealthPartners Institute; Other
Eligibility: 18 Years to 75 Years
Enrollment: 91 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Overweight and Obesity, PreDiabetes, Insulin Resistance
Interventions: CGM; Device
Lead sponsor: Mary Ellen Vajravelu, MD; Other
Eligibility: 8 Years to 18 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Type 1 Diabetes Mellitus
Interventions: Predictive Low Glucose Suspend Algorithm ON, Predictive Low Glucose Suspend Algorithm OFF; Device
Lead sponsor: Stanford University; Other
Eligibility: 12 Years to 46 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 2
States / cities: Stanford, California • Aurora, Colorado

Conditions: Diabetes Mellitus, Type 2
Interventions: Blinded CGM, real-time CGM; Device
Lead sponsor: Jaeb Center for Health Research; Other
Eligibility: 18 Years and older
Enrollment: 166 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 6
States / cities: Aurora, Colorado • Atlanta, Georgia • Baltimore, Maryland + 3 more

Conditions: Hypoglycemia
Interventions: Entry of demographic and medical history data into a deidentified database, Blood sample for DNA analysis, Stool sample for microbiome analysis, Mixed meal tolerance test, Continuous glucose monitoring, activity monitor; Other · Genetic · Diagnostic Test
Lead sponsor: Joslin Diabetes Center; Other
Eligibility: 18 Years to 70 Years
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hemodialysis, Diabete Mellitus, Continuous Glucose Monitoring
Interventions: Continuous glucose monitoring (CGM), Usual care (Self-monitored blood glucose); Device
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years to 99 Years
Enrollment: 122 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Orange, California

Conditions: Diabetes Mellitus
Interventions: Phase 1- Introduction to Dexcom G6 CGM; Device
Lead sponsor: DexCom, Inc.; Industry
Eligibility: 2 Years and older
Enrollment: 85 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Henderson, Nevada

Conditions: Post-Bariatric Hypoglycemia
Interventions: Use of Continuous Glucose Monitor (CGM), Use of "Cardea Solo" monitoring; Behavioral · Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Stanford, California

Conditions: Diabetes During Pregnancy
Interventions: High-Protein Beverage (Genius Gourmet Sparkling Protein Water), Standard Clear Liquid Diet, Continuous Glucose Monitoring (Abbott Freestyle Libre); Dietary Supplement · Other · Device
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Diabetes Mellitus, Type 1 Diabetes, Diabetes Mellitus, Type 1
Interventions: Bionic Pancreas (BP) with Aspart or Lispro, Bionic Pancreas with Fiasp (BPFiasp), Usual Care (UC), BP Guidance Insulin Dosing; Combination Product · Other
Lead sponsor: Jaeb Center for Health Research; Other
Eligibility: 6 Years and older
Enrollment: 440 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 16
States / cities: Orange, California • San Diego, California • Stanford, California + 13 more

Conditions: Type 2 Diabetes
Interventions: Continuous Glucose Monitoring (CGM)-based titration algorithm implemented in DiAs; Device
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 2
States / cities: New York, New York • Charlottesville, Virginia

Conditions: Type 1 Diabetes Mellitus
Interventions: Decision Support System, Usual Care; Device · Other
Lead sponsor: Daniel Chernavvsky, MD; Other
Eligibility: 21 Years to 65 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
Interventions: Real-time CGM data; Device
Lead sponsor: Scripps Whittier Diabetes Institute; Other
Eligibility: 18 Years and older
Enrollment: 157 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Type 1 Diabetes Mellitus
Interventions: Dexcom CGM; Device
Lead sponsor: Jaeb Center for Health Research; Other
Eligibility: 60 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 22
States / cities: Beverly Hills, California • La Jolla, California • Aurora, Colorado + 17 more

Conditions: Type 2 Diabetes
Interventions: Unblinded CGM/Nutrition Therapy, Blinded CGM/Nutrition Therapy, Unblinded CGM/No Nutrition Therapy, Blinded CGM/No Nutrition Therapy; Behavioral
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Heart Failure, Diabetes Mellitus
Interventions: Libre 2 rt-CGM, POC BG + Blinded CGM; Device · Diagnostic Test
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Gestational Diabetes Mellitus in Pregnancy
Interventions: Blinded CGM; Device
Lead sponsor: Woman's; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 61 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Diabetes Mellitus, Type 2
Interventions: CGM device with diabetic education, CGM education and a follow up protocol.; Device
Lead sponsor: Intermountain Health Care, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Logan, Utah

Conditions: Type 2 Diabetes, Hip Osteoarthritis, Knee Osteoarthritis
Interventions: DexCom G6 continuous glucose monitor; Device
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 30 Years to 80 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Kidney Transplant; Complications, Diabetes Mellitus, Type 2, Insulin Dependent Diabetes
Interventions: Dexcom G6, Dexcom G6 blinded sensor; Device
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Sacramento, California

Search by objective public record fields.

FreeStyle Libre 2 Discharge Trial

Feasibility and Clinical Utility of the Dexcom G6 Continuous Glucose Monitoring Device for Type 2 Diabetes

Validation of Machine Learning Based Personalized Nutrition Algorithm to Reduce Postprandial Glycemic Excursions Among North American Individuals With Newly Diagnosed Type 2 Diabetes

Evaluating Glial Acetate Metabolism as a Biomarker of Hypoglycemic Complications in Diabetic Patients

Modal Day Analysis of Self Monitoring Blood Glucose Versus Continuous Glucose Monitoring

Continuous Glucose Monitors (CGM) for Type 2 Diabetes (T2D) Risk Evaluation

Development of Algorithms for a Hypoglycemic Prevention Alarm: Closed Loop Study

Time in Glucose Hospital Target

Mechanisms of Hypoglycemia in Patients Without Diabetes

Continuous Glucose Monitoring in Dialysis Patients to Overcome Dysglycemia Trial

Assessing Non-adjunctive CGM Safety at Home and in New Markets

Role of Nutrient Transit in Hyperinsulinemic Hypoglycemia

Fueling Labor: Protein Supplementation for Intrapartum Glucose Control

The Insulin-Only Bionic Pancreas Pivotal Trial

The Effect and Safety of a Novel CGM-Based Titration Algorithm for Basal Insulin in T2DM Participants.

Feasibility of a Decision Support System to Reduce Glucose Variability in Subject With T1DM

Managing Type 1 and High Risk Type 2 Diabetes in the Hospital Setting: Glucose as a Vital Sign

Wireless Innovation for Seniors With Diabetes Mellitus

Individualized Diabetes Education Assisted by CGM (IDEA-CGM)

CGM Use in Heart Failure

The CGMS in GDM Labor and Delivery Study

Diabetes Discharge Transitional CGM Study (DDT-CGM)

DexCom Hospital Study-CGM Directed Insulin Delivery

Use of CGM in Kidney Transplant Recipients